Richard Geoffrey Vile, PhD

Professor, Rochester, MN, Molecular Medicine

EmailVile.Richard@mayo.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Richard Geoffrey Vile is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

10 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

2 Not started
6 Finished

Research Training Program in Neuro-Oncology
O'Neill, B. P. & Vile, R. G.
Project: Research project
Mayo Clinic Hepatobiliary SPORE
Mandrekar, S. J., Torbenson, M., Gores, G. J., Alberts, S. R. & Vile, R. G.
Project: Research project
Enhancing Therapy of Primary and Recurrent Tumors With Systemic Oncolytic Virus
Vile, R. G. & Kinney, L.
5/7/14 → 4/30/19
Project: Research project
Enhancing Systemic Delivery of Oncolytic Viruses for Cancer Therapy
Vile, R. G. & Kinney, L.
1/1/09 → 11/30/14
Project: Research project
Autoimmunity and anti tumor immunity outside of the melanocyte/melanoma paradigm
Vile, R. G. & Kinney, L.
7/1/08 → 5/31/14
Project: Research project

13528 Citations
67 Scopus h-Index
223 Article
41 Review article
16 Comment/debate
4 Editorial
7 More

APOBEC3B-mediated corruption of the tumor cell immunopeptidome induces heteroclitic neoepitopes for cancer immunotherapy
Driscoll, C. B., Schuelke, M. R., Kottke, T., Thompson, J. M., Wongthida, P., Tonne, J. M., Huff, A. L., Miller, A., Shim, K. G., Molan, A., Wetmore, C., Selby, P., Samson, A., Harrington, K., Pandha, H., Melcher, A., Pulido, J. S., Harris, R., Evgin, L. & Vile, R. G., Dec 1 2020, In : Nature communications. 11, 1, 790.
Research output: Contribution to journal › Article › peer-review

Open Access
3 Scopus citations
Combining BRAF inhibition with oncolytic herpes simplex virus enhances the immune-mediated antitumor therapy of BRAF-mutant thyroid cancer
Crespo-Rodriguez, E., Bergerhoff, K., Bozhanova, G., Foo, S., Patin, E. C., Whittock, H., Buus, R., Haider, S., Muirhead, G., Thway, K., Newbold, K., Coffin, R. S., Vile, R. G., Kim, D., McLaughlin, M., Melcher, A. A., Harrington, K. J. & Pedersen, M., Aug 5 2020, In : Journal for ImmunoTherapy of Cancer. 8, 2, 698.
Research output: Contribution to journal › Article › peer-review

Open Access
Generation of a Tumor-Specific Chemokine Gradient Using Oncolytic Vesicular Stomatitis Virus Encoding CXCL9
Eckert, E. C., Nace, R. A., Tonne, J. M., Evgin, L., Vile, R. G. & Russell, S. J., Mar 27 2020, In : Molecular Therapy - Oncolytics. 16, p. 63-74 12 p.
Research output: Contribution to journal › Article › peer-review

Open Access
3 Scopus citations
Oncolytic virus-derived type I interferon restricts CAR T cell therapy
Evgin, L., Huff, A. L., Wongthida, P., Thompson, J., Kottke, T., Tonne, J., Schuelke, M., Ayasoufi, K., Driscoll, C. B., Shim, K. G., Reynolds, P., Monie, D. D., Johnson, A. J., Coffey, M., Young, S. L., Archer, G., Sampson, J., Pulido, J., Perez, L. S. & Vile, R., Dec 1 2020, In : Nature communications. 11, 1, 3187.
Research output: Contribution to journal › Article › peer-review

Open Access
3 Scopus citations
The PERK Inhibitor GSK2606414 Enhances Reovirus Infection in Head and Neck Squamous Cell Carcinoma via an ATF4-Dependent Mechanism
McLaughlin, M., Pedersen, M., Roulstone, V., Bergerhoff, K. F., Smith, H. G., Whittock, H., Kyula, J. N., Dillon, M. T., Pandha, H. S., Vile, R., Melcher, A. A. & Harrington, K. J., Mar 27 2020, In : Molecular Therapy - Oncolytics. 16, p. 238-249 12 p.
Research output: Contribution to journal › Article › peer-review

Open Access
1 Scopus citations